← Leaderboards
Maciej S Lesniak
Northwestern University
$30,155,882
Attributed
$32,277,477
Total exposure
19
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$49,441,560 · 20
By mechanism
P50$22,795,593 · 9
R01$12,477,416 · 6
R35$8,019,531 · 2
U01$4,932,285 · 1
K08$828,722 · 1
R21$388,013 · 1
Top collaborators
- Jason Miska5 shared
- Irina V Balyasnikova4 shared
- Valentyn Novosad1 shared
- Elena Rozhkova1 shared
Most similar at Northwestern University
Same institution · by research overlap
- Chad A. Mirkin$20,335,625
- John A Kessler$26,477,132
- Timothy L Sita$223,924
- Bin Zhang$12,434,815
- Jennifer Rachel Ferrer$75,556
Others in their field
Top investigators on “Malignant Neoplasm Of Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$98,484,899
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,639,263
- Robert H Vonderheide · University Of Pennsylvania$61,781,043
- Norman Wolmark · Nsabp Foundation, Inc.$55,112,681
Research focus
Malignant Neoplasm Of BrainBrain NeoplasmsMalignant NeoplasmsTumorBrainGlioblastomaGliomaBaseMalignant GliomaCellsClinical TrialsTranslational ApproachAdultRadiation TherapyProgramsOperative Surgical ProceduresNeuraxisRecurrenceImmune ResponseResearch PersonnelIn VivoPre-ClinicalVirusMediating
Grant awards (90)
SPORE for Translational Approaches to Brain Cancer$2,140,963
P50 · FY2025 · CA · contact PI
Emerging Strategies for Therapy of Metastatic Brain Cancer$947,808
R35 · FY2025 · CA · contact PI
Neural Stem Cell Based Virotherapy for Malignant Glioma$304,995
P50 · FY2025 · CA · contact PI
Developmental Research Program$178,250
P50 · FY2025 · CA · contact PI
Administrative Core$141,058
P50 · FY2025 · CA · contact PI
Career Enhancement Program$101,788
P50 · FY2025 · CA · contact PI
SPORE for Translational Approaches to Brain Cancer$2,076,151
P50 · FY2024 · CA · contact PI
Emerging Strategies for Therapy of Metastatic Brain Cancer$895,779
R35 · FY2024 · CA · contact PI
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma$364,720
R01 · FY2024 · NS · contact PI
Neural Stem Cell Based Virotherapy for Malignant Glioma$287,309
P50 · FY2024 · CA · contact PI
Developmental Research Program$178,011
P50 · FY2024 · CA · contact PI
Administrative Core$140,870
P50 · FY2024 · CA · contact PI
Career Enhancement Program$101,650
P50 · FY2024 · CA · contact PI
SPORE for Translational Approaches to Brain Cancer$2,044,971
P50 · FY2023 · CA · contact PI
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma$376,000
R01 · FY2023 · NS · contact PI
Neural Stem Cell Based Virotherapy for Malignant Glioma$278,358
P50 · FY2023 · CA · contact PI
Developmental Research Program$172,466
P50 · FY2023 · CA · contact PI
Administrative Core$163,659
P50 · FY2023 · CA · contact PI
Career Enhancement Program$98,484
P50 · FY2023 · CA · contact PI
SPORE for Translational Approaches to Brain Cancer$2,138,999
P50 · FY2022 · CA · contact PI
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma$376,000
R01 · FY2022 · NS · contact PI
Project 1: Neural Stem Cell Based Oncolytic Virotherapy of Malignant Glioma$278,494
P50 · FY2022 · CA · contact PI
Developmental Research Program$142,078
P50 · FY2022 · CA · contact PI
Administrative Core$99,951
P50 · FY2022 · CA · contact PI
SPORE for Translational Approaches to Brain Cancer$2,139,000
P50 · FY2021 · CA · contact PI
Therapeutic Targeting of Malignant Glioma Stem Cells$916,993
R35 · FY2021 · CA · contact PI
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma$373,258
R01 · FY2021 · NS · contact PI
Project 1: Neural Stem Cell Based Oncolytic Virotherapy of Malignant Glioma$288,015
P50 · FY2021 · CA · contact PI
Developmental Research Program$175,748
P50 · FY2021 · CA · contact PI
Administrative Core$129,103
P50 · FY2021 · CA · contact PI
SPORE for Translational Approaches to Brain Cancer$2,184,999
P50 · FY2020 · CA · contact PI
Therapeutic Targeting of Malignant Glioma Stem Cells$916,993
R35 · FY2020 · CA · contact PI
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma$371,300
R01 · FY2020 · NS · contact PI
phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma$342,106
P50 · FY2020 · CA · contact PI
Project 1: Neural Stem Cell Based Oncolytic Virotherapy of Malignant Glioma$339,278
P50 · FY2020 · CA · contact PI
Developmental Research Program$167,738
P50 · FY2020 · CA · contact PI
Administrative Core$122,041
P50 · FY2020 · CA · contact PI
SPORE for Translational Approaches to Brain Cancer$2,139,000
P50 · FY2019 · CA · contact PI
Therapeutic Targeting of Malignant Glioma Stem Cells$889,484
R35 · FY2019 · CA · contact PI
Metabolic Control of Immune Suppression in Gliomas$413,173
R01 · FY2019 · NS · contact PI
Project 1: Neural Stem Cell Based Oncolytic Virotherapy of Malignant Glioma$328,396
P50 · FY2019 · CA · contact PI
Developmental Research Program$164,207
P50 · FY2019 · CA · contact PI
Administrative Core$140,790
P50 · FY2019 · CA · contact PI
SPORE for Translational Approaches to Brain Cancer$2,300,000
P50 · FY2018 · CA · contact PI
Therapeutic Targeting of Malignant Glioma Stem Cells$902,878
R35 · FY2018 · CA · contact PI
Metabolic Control of Immune Suppression in Gliomas$413,173
R01 · FY2018 · NS · contact PI
Administrative Core$255,557
P50 · FY2018 · CA · contact PI
Project 1: Neural Stem Cell Based Oncolytic Virotherapy of Malignant Glioma$255,555
P50 · FY2018 · CA · contact PI
Developmental Research Program$255,555
P50 · FY2018 · CA · contact PI
Therapeutic Targeting of Malignant Glioma Stem Cells$916,993
R35 · FY2017 · CA · contact PI
Metabolic Control of Immune Suppression in Gliomas$484,938
R01 · FY2017 · NS · contact PI
Intranasal Stem-Cell Based Therapy for Glioblastoma$405,762
R01 · FY2017 · NS · contact PI
Therapeutic Targeting of Malignant Glioma Stem Cells$923,113
R35 · FY2016 · CA · contact PI
Intranasal Stem-Cell Based Therapy for Glioblastoma$407,515
R01 · FY2016 · NS · contact PI
Therapeutic Targeting of Malignant Glioma Stem Cells$623,888
R35 · FY2015 · CA · contact PI
Metabolic Control of Immune Suppression in Gliomas$528,130
R01 · FY2015 · NS · contact PI
Metabolic Control of Immune Suppression in Gliomas$506,747
R01 · FY2015 · NS · contact PI
Magnetic-vortex microdiscs for glioma therapy$494,193
R01 · FY2015 · NS · contact PI
Magnetic-vortex microdiscs for glioma therapy$471,467
R01 · FY2015 · NS · contact PI
Intranasal Stem-Cell Based Therapy for Glioblastoma$419,228
R01 · FY2015 · NS · contact PI
Regulatory T Cells and Oncolytic Virotherapy of Glioma$234,684
R01 · FY2015 · CA · contact PI
Therapeutic Targeting of Malignant Glioma Stem Cells$85,602
R35 · FY2015 · CA · contact PI
Regulatory T Cells and Oncolytic Virotherapy of Glioma$83,331
R01 · FY2015 · CA · contact PI
Magnetic-vortex microdiscs for glioma therapy$503,933
R01 · FY2014 · NS · contact PI
Intranasal Stem-Cell Based Therapy for Glioblastoma$419,228
R01 · FY2014 · NS · contact PI
Regulatory T Cells and Oncolytic Virotherapy of Glioma$308,475
R01 · FY2014 · CA · contact PI
Neural Stem Cell Based Virotherapy for Malignant Glioma$1,138,522
U01 · FY2013 · NS · contact PI
Magnetic-vortex microdiscs for glioma therapy$513,562
R01 · FY2013 · NS · contact PI
Regulatory T Cells and Oncolytic Virotherapy of Glioma$318,015
R01 · FY2013 · CA · contact PI
Regulatory T Cells in Malignant Glioma$295,150
R01 · FY2013 · CA · contact PI
Neural Stem Cell Based Virotherapy for Malignant Glioma$1,353,977
U01 · FY2012 · NS · contact PI
Magnetic-vortex microdiscs for glioma therapy$547,634
R01 · FY2012 · NS · contact PI
Regulatory T Cells in Malignant Glioma$313,989
R01 · FY2012 · CA · contact PI
Conditionally Replicative Adenoviral Vectors for Malignant Glioma$302,688
R01 · FY2012 · CA · contact PI
Neural Stem Cell Based Virotherapy for Malignant Glioma$1,238,138
U01 · FY2011 · NS · contact PI
Regulatory T Cells in Malignant Glioma$315,989
R01 · FY2011 · CA · contact PI
Conditionally Replicative Adenoviral Vectors for Malignant Glioma$302,856
R01 · FY2011 · CA · contact PI
Neural Stem Cell Based Virotherapy for Malignant Glioma$1,201,648
U01 · FY2010 · NS · contact PI
Regulatory T Cells in Malignant Glioma$338,344
R01 · FY2010 · CA · contact PI
Conditionally Replicative Adenoviral Vectors for Malignant Glioma$312,391
R01 · FY2010 · CA · contact PI
Regulatory T Cells in Malignant Glioma$325,170
R01 · FY2009 · CA · contact PI
Conditionally Replicative Adenoviral Vectors for Malignant Glioma$312,556
R01 · FY2009 · CA · contact PI
Development of an Adenoviral Vector with Chimeric Fiber for Malignant Glioma$172,688
R21 · FY2009 · CA · contact PI
Targeted Adenoviral Gene Therapy for Malignant Glioma$165,078
K08 · FY2009 · NS · contact PI
Conditionally Replicative Adenoviral Vectors for Malignant Glioma$323,817
R01 · FY2008 · CA · contact PI
Development of an Adenoviral Vector with Chimeric Fiber for Malignant Glioma$215,325
R21 · FY2008 · CA · contact PI
Targeted Adenoviral Gene Therapy for Malignant Glioma$165,078
K08 · FY2008 · NS · contact PI
Targeted Adenoviral Gene Therapy for Malignant Glioma$165,078
K08 · FY2007 · NS · contact PI
Targeted Adenoviral Gene Therapy for Malignant Glioma$168,410
K08 · FY2006 · NS · contact PI
Targeted Adenoviral Gene Therapy for Malignant Glioma$165,078
K08 · FY2005 · NS